Precipio, Inc. (PRPO) Stock

Healthcare · Diagnostics & Research · Member of Other US Stocks

Precipio, Inc. (PRPO) closed at USD 22.25 on 2026-10-14, a change of +6 % over the past year, with a market capitalization of USD 40.35M.

Precipio, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Precipio, Inc. key figures

Previous close

USD 22.25 (2026-10-14)

1-year change

+6 %

Market cap

USD 40.35M

Enterprise value

USD 40.86M

P/E ratio (trailing)

-35.22

P/E ratio (forward)

57.80

EPS (trailing)

-0.64

EPS (forward)

0.39

PEG ratio

n/a

Price to book

2.73

Revenue growth

24.2 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.47

Employees

61

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Precipio, Inc.

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Precipio, Inc. and compare it with other stocks.